Localization of cb1 receptors in rat`s periaqueductal gray after immobilization stress and effects of peptide tyr-w-mif- 1. immunocytochemical study by Malinova, Lina et al.
Scripta Scientifica Medica, vol. 45, 2013, suppl. 1, pp. 39-42
Copyright © Medical University of Varna   39
ORIGINAL ARTICLES
LOCALIZATION OF CB1 RECEPTORS IN RAT’S 
PERIAQUEDUCTAL GRAY AFTER IMMOBILIZATION 
STRESS AND EFFECTS OF PEPTIDE TYR-W-MIF- 1.  
IMMUNOCYTOCHEMICAL STUDY
Lina Malinova1, Hristina Nocheva2, Adriana Bocheva2, Boycho Landzhov1,  
Elena Dzambazova3,  Anastasia Bozhilova-Pastirova1
1Department of Anatomy, Histology and Embryology  
2Department of Pathophysiology, Medical University of Sofia 
3Department of Physiology and Pathophysiology, Sofia University, ,,St. Kliment Ohridski”
INTRODUCTION
The PAG is a mesencephalic structure that 
surrounds the cerebral aqueduct and can be divided 
along its rostrocaudal axis into dorsomedial, 
dorsolateral (dlPAG), lateral, and ventrolateral 
columns (3). The previous data have shown that 
PAG is a significant modulator involved in neuronal 
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circuits taking part in the stress-induced analgesia 
(4). Stress activates neural systems that inhibit 
pain sensation. This adaptive response depends on 
neuronal pathways that project from the cortical 
neurons to the midbrain periaqueductal gray (PAG) 
and descend to the brainstem rostro-ventro-medial 
medulla and dorsal horn of the spinal cord and 
suppresses nociception (8,20).
The CB1 receptor expression was detected 
in regions influencing a number of key functions, 
including mood, motor coordination, autonomic 
function, memory, sensation, cognition and stress. 
Electron microscopy studies demonstrated CB1 
receptors predominantly on presynaptic terminals 
(11,15) but they were found also on postsynaptic 
structures and glia (3). They activate G-proteins 
that inhibit adenylate cyclase and calcium channels 
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and enhance potassium currents, thereby reducing 
neural firing and neurotransmitter release (18). 
Tyr-W-MIF-1 is a member of Tyr-MIF-1 family 
of neuropeptides which have been isolated from 
human parietal cortex and bovine hypothalamic 
tissue. Previous studies showed that Tyr-MIF-1 
family members are attractive candidates for opiate 
modulators. It is known that these peptides participate 
in different types of physiological processes including 
pain and evolution of stress. Tyr-W-MIF-1 has high 
selectivity for μ-opioid receptors (12).
The aim of this study was to investigate 
the effects of the Tyr-W-MIF-1 neuropeptide on 
expression of CB1 immunoreactive neurons in rat’s 
periaqueductal gray after immobilization stress 
using immunohistochemistry.  
MATERIALS AND METHODS
Animals
The experiments were carried out on male 
Wistar rats kept under normal conditions at ambient 
room temperature. Each group included 3 rats. 
Acute model of immobilization stress (IS) 
The animals were placed for 1 hour in a plastic 
tube with adjustable plaster tape on the outside so 
that the animals were unable to move. There were 
holes for breathing. 
After the completion of the stress model the 
animals were injected with Tyr-W-MIF-1 (1mg/
kg) obtained from Sigma. The neuropeptide was 
dissolved in sterile saline (0.9% NaCl) solution and 
was injected intraperitoneally (i.p). 
Immunohistochemistry 
After stress procedure, 24 h later the animals 
were anaesthetized with Thiopental (40 mg/kg, 
i.p.) and perfused through the heart with fixative 
(4% paraformaldehyde in 0.1M phosphate buffer, 
pH 7,2). Brains were removed and sectioned by 
freezing microtome. The coronal sections we took 
between bregma +1.70 - +5.2. Free-floating sections 
were preincubated for 1 h in 5% normal goat serum 
in PBS. Afterwards, incubation of the sections was 
performed in a solution of the primary antibody 
for 48 h at room temperature. We used a polyclonal 
anti-CB1 antibody (Santa Cruz, USA), in a dilution 
of 1:1000. Then sections were incubated with 
biotinylated anti-mouse IgG (dilution, 1:500) for 
2 h and in a solution of avidin-biotin-peroxidase 
complex (Vectastain Elite ABC reagent; Vector Labs., 
dilution 1:250) for 1 h. This step was followed by 
washing in PBS and then in 0.05 M Tris-HCl buffer, 
pH 7.6, which preceded incubation of sections in a 
solution of 0.05% 3,3‘-diaminobenzidine (DAB, 
Sigma) containing 0.01% H2o2 for 10 min at room 
temperature for the visualization.
All procedures were approved by the Animal 
Care and Use Committee of the Medical University, 
Sofia.
RESULTS AND DISCUSSION 
Immunohistochemistry  labeling in PAG 
sections was viewed using a light microscope. 
Images from three groups of animals were analyzed 
to determine the distribution of CB1 receptor 
immunoreactivity. In control animals CB1 expression 
was diffuse and extensive (Fig. 1). We found it on 
some cell bodies as well as in axons and dendrites 
of the PAG. In the neurons the CB 1 receptors were 
mostly expressed on the cell membranes. Even there 
is also a great deal of CB1 receptor immunoreactivity 
outside of cell bodies. our results showed increased 
expression of CB1 immunoreactive neurons in 
the PAG after 1 h immobilization stress compared 
with intact animals (Fig. 2). Injection of Tyr-W-
MIF-1 (1 mg/kg, i.p.) immediately after stress 
procedure apparently decreased expression of CB1 
immunoreactive neurons in the PAG (Fig. 3). 
Fig. 1. Distribution of CB1 immunoreactive neurons in PAG, 
intact animals. The CB 1 receptors were mostly expressed on 
the cell bodies as well as in axons and dendrites (x400)
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The periaqueductal gray is part of a descending 
pain modulatory system that, when activated, 
produces widespread and profound antinociception. 
Furthermore, except opioid stimulation of opioid 
receptors, the dorsolateral PAG is specialized to 
produce cannabinoid-mediated stress-induced 
analgesia (10). 
There are no data available about the effects of 
Tyr-MIF-1 peptides on expression of CB1 receptors 
in rat’s PAG after any kind of stress. our previous 
data demonstrated that Tyr-W-MIF-1 injected 
alone in naive rats had analgesic effect and it also 
decreased the effects of morphine, L-NAME and 
immobilization stress-induced analgesia, which 
corresponds to the hypothesis about anti-opioid 
peptides (5,6,7). 
It’s known that members of Tyr-MIF-1 family 
of peptides are particularly attractive candidates 
for opiate modulators. Unlike most other putative 
opiate-modulating peptides, they bind to the μ 
opiate receptor and to their own non-opiate sites (7). 
Immobilization stress-induced antinociception is 
also reduced in rats by Tyr-W-MIF-1, as measured by 
the paw-pressure test (6). This opioid effect is greater 
when the tetrapeptide is injected after exposure to 
the stress. Tyr-W-MIF-1 also decreases the analgesic 
effect of morphine in the tail-flick and paw-pressure 
tests (5). Now, the results in our experiments showed 
that Tyr-W-MIF-1 injected in animals immediately 
after immobilization stress procedure apparently 
decreased expression of CB1-immunoreactive 
neurons. Thus, the investigated neuropeptides 
counteract the effect of stress and we may confirm 
its anti-stressor effect. 
There are scientific data that CB1 and µ-opioid 
receptors are each found in somatodendritic profiles 
in the PAG (14). In the dorsal horn of the spinal cord, 
both receptor types co-localize in dendrites (1). 
Previous reports have shown that chronic drug 
administration can induce changes in the density of 
the CB1 and μ- opioid receptors in several sites in 
the central nervous system. In reward-related brain 
areas, there is a reciprocal up-regulation of CB1 and 
μ-receptors after chronic drug exposure. Similarly, 
chronic morphine administration increases the 
density of both CB1 and CB2 receptors in the dorsal 
horn of the spinal cord (9).
The behavioral and anatomical data cited 
above suggest that CB1 and μ-receptors have direct 
interactions in the PAG. opioids and cannabinoids 
have been shown to have analgesic properties. 
Systemic co-administration of cannabinoid 
and opioid agonists results in synergistic 
antinociception (13), and systemic pre-treatment 
or co-administration of cannabinoids attenuates 
the development of morphine tolerance (17). It is 
possible that cannabinoid/opioid interactions occur 
between neurons where the receptors are not co-
localized on the same cell, but interact synaptically. 
Endocannabinoids are retrograde messengers, with 
CB1 receptors located on presynaptic terminals (2, 
19). Thus, CB1-receptive terminals contacting μ 
receptor-immunoreactive cells could be alternative 
sites of opioid/cannabinoid interaction. 
Fig. 2. Distribution of CB1 immunoreactive neurons in 
PAG after 1 h immobilization stress (x400)
Fig. 3. Distributions of CB1 immunoreactive neurons in 
PAG after injection of Tyr-K-MIF-1 (x400)
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CONCLUSION
In conclusion our results showed that 
expression of CB1 immunoreactive neurons in rat’s 
PAG were increased by immobilization stress.  To 
our knowledge, this is the first report showing that 
neuropeptide Tyr-W-MIF-1 decreased stress-induced 
CB1 expression mentioned above probably by opioid/
cannabinoid interaction. Further studies are needed 
to understand the exact role of Tyr-W-MIF-1 on CB1 
receptors in response to immobilization stress.
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